A selective human H4-receptor agonist:: (-)-2-cyano-1-methyl-3-{(2R,5R)-5-[1H-imidazol-4(5)-yl]tetrahydrofuran-2-yl}methylguanidine

被引:59
作者
Hashimoto, T
Harusawa, S
Araki, L
Zuiderveld, OP
Smit, MJ
Imazu, T
Takashima, S
Yamamoto, Y
Sakamoto, Y
Kurihara, T
Leurs, R
Bakker, RA
Yamatodani, A [1 ]
机构
[1] Osaka Univ, Fac Med, Grad Sch Allied Hlth Sci, Dept Bioinformat, Osaka 5650871, Japan
[2] Vrije Univ Amsterdam, Fac Chem, Dept Pharmacol, Leiden Amsterdam Ctr Drug Res,Div Med Chem, NL-1081 HV Amsterdam, Netherlands
[3] Osaka Univ Pharmaceut Sci, Dept Synthet Organ Chem, Takatsuki, Osaka 5691094, Japan
[4] Azwell Inc, R&D Div, Ibaraki, Osaka 5670806, Japan
关键词
D O I
10.1021/jm0300025
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 16 compounds related to chiral 4(5)-(5-aminomethyltetrahydrofuran-2-yl)imidazoles (1) have been designed, synthesized, and examined in vitro by radioligand displacement studies and functional assays for both the human H-3- and H-4-receptors expressed in SK-N-MC cells. Among them, the (2S,5S)-isomer 1d of amino compounds showed approximately 300-fold higher selectivity at the H-3-receptor than the H-4-receptor. On the other hand, (2R,5S)- and (2R,5R)-cyanoguanidines 3b and 3c, in which the amino group of the compounds 1b and 1c was substituted by the cyanoguanidino moiety, bound to the H-4-receptor with a pEC(50) value of 6.65 and 7.11, respectively, and had >40-fold selectivities over the H3-receptor. As such, 3b and 3c are the first selective H-4 receptor agonists.
引用
收藏
页码:3162 / 3165
页数:4
相关论文
共 13 条
[1]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[2]   Structure and expression of the human histamine H4-receptor gene [J].
Cogé, F ;
Guénin, SP ;
Rique, H ;
Boutin, JA ;
Galizzi, JP .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 284 (02) :301-309
[3]   Synthesis of imifuramine and its stereoisomers exhibiting histamine H3 agonistic activity [J].
Harusawa, S ;
Imazu, T ;
Takashima, S ;
Araki, L ;
Ohishi, H ;
Kurihara, T ;
Yamamoto, Y ;
Yamatodani, A .
TETRAHEDRON LETTERS, 1999, 40 (13) :2561-2564
[4]   Synthesis of 4(5)-[5-(aminomethyl)tetrahydrofuran-2-yl- or 5-(aminomethyl)-2,5-dihydrofuran-2-yl]imidazoles by efficient use of a PhSe group:: Application to novel histamine H3-ligands [J].
Harusawa, S ;
Imazu, T ;
Takashima, S ;
Araki, L ;
Ohishi, H ;
Kurihara, T ;
Sakamoto, Y ;
Yamamoto, Y ;
Yamatodani, A .
JOURNAL OF ORGANIC CHEMISTRY, 1999, 64 (23) :8608-8615
[5]  
Liu CL, 2001, J PHARMACOL EXP THER, V299, P121
[6]   Cloning and pharmacological characterization of a fourth histamine receptor (H4) expressed in bone marrow [J].
Liu, CL ;
Ma, XJ ;
Jiang, XX ;
Wilson, SJ ;
Hofstra, CL ;
Blevitt, J ;
Pyati, J ;
Li, XB ;
Chai, WY ;
Carruthers, N ;
Lovenberg, TW .
MOLECULAR PHARMACOLOGY, 2001, 59 (03) :420-426
[7]   Cloning and functional expression of the human histamine H3 receptor [J].
Lovenberg, TW ;
Roland, BL ;
Wilson, SJ ;
Jiang, XX ;
Pyati, J ;
Huvar, A ;
Jackson, MR ;
Erlander, MG .
MOLECULAR PHARMACOLOGY, 1999, 55 (06) :1101-1107
[8]  
Morse KL, 2001, J PHARMACOL EXP THER, V296, P1058
[9]   Molecular cloning and characterization of a new human histamine receptor, HH4R [J].
Nakamura, T ;
Itadani, H ;
Hidaka, Y ;
Ohta, M ;
Tanaka, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 279 (02) :615-620
[10]   Discovery of a novel member of the histamine receptor family [J].
Nguyen, T ;
Shapiro, DA ;
George, SR ;
Setola, V ;
Lee, DK ;
Cheng, R ;
Rauser, L ;
Lee, SP ;
Lynch, KR ;
Roth, BL ;
O'Dowd, BF .
MOLECULAR PHARMACOLOGY, 2001, 59 (03) :427-433